Menu
Back to Journals » Cancer Management and Research » Volume 5
Cancer Management and Research
ISSN: 1179-1322
- View all (4486)
- Volume 15, 2023 (45)
- Volume 14, 2022 (330)
- Volume 13, 2021 (890)
- Volume 12, 2020 (1256)
- Volume 11, 2019 (969)
- Volume 10, 2018 (645)
- Volume 9, 2017 (89)
- Volume 8, 2016 (17)
- Volume 7, 2015 (33)
- Volume 6, 2014 (43)
- Volume 5, 2013 (41)
- Volume 4, 2012 (47)
- Volume 3, 2011 (32)
- Volume 2, 2010 (32)
- Volume 1, 2009 (17)
Archive: Volume 5, 2013
Daily baseline skin care in the prevention, treatment, and supportive care of skin toxicity in oncology patients: recommendations from a multinational expert panel
Bensadoun RJ, Humbert P, Krutman J, Luger T, Triller R, Rougier A, Seite S, Dreno B
Cancer Management and Research 2013, 5:401-408
Published Date: 9 December 2013
Personalized treatment for advanced colorectal cancer: KRAS and beyond
Patel GS, Karapetis CS
Cancer Management and Research 2013, 5:387-400
Published Date: 21 November 2013
Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC)
Rossi L, Vakiarou F, Zoratto F, Bianchi L, Papa A, Basso E, Verrico M, Lo Russo G, Evangelista S, Rinaldi G, Perrone-Congedi F, Spinelli GP, Stati V, Caruso D, Prete A, Tomao S
Cancer Management and Research 2013, 5:377-385
Published Date: 19 November 2013
The claudin family of proteins in human malignancy: a clinical perspective
Ding L, Lu Z, Lu Q, Chen YH
Cancer Management and Research 2013, 5:367-375
Published Date: 8 November 2013
Benefit risk assessment and update on the use of docetaxel in the management of breast cancer
Alken S, Kelly CM
Cancer Management and Research 2013, 5:357-365
Published Date: 14 October 2013
Prospective study evaluating the radiosensitizing effect of reduced doses of temozolomide in the treatment of Egyptian patients with glioblastoma multiforme
Gaber M, Selim H, El-Nahas T
Cancer Management and Research 2013, 5:349-356
Published Date: 8 October 2013
Antiangiogenic treatment in hepatocellular carcinoma: the balance of efficacy and safety
Welker MW, Trojan J
Cancer Management and Research 2013, 5:337-347
Published Date: 8 October 2013
The prognostic value of ERCC1 and RRM1 gene expression in completely resected non-small cell lung cancer: tumor recurrence and overall survival
Tantraworasin A, Saeteng S, Lertprasertsuke N, Arayawudhikul N, Kasemsarn C, Patumanond J
Cancer Management and Research 2013, 5:327-336
Published Date: 3 October 2013
Focal low-dose rate brachytherapy for the treatment of prostate cancer
Tong WY, Cohen G, Yamada Y
Cancer Management and Research 2013, 5:315-325
Published Date: 13 September 2013
Critical appraisal of the potential use of cannabinoids in cancer management
Cridge BJ, Rosengren RJ
Cancer Management and Research 2013, 5:301-313
Published Date: 30 August 2013
Perspectives on the immunologic microenvironment of astrocytomas
Hewedi IH, Radwan NA, Shash LS, Elserry TH
Cancer Management and Research 2013, 5:293-299
Published Date: 30 August 2013
AKT-independent PI3-K signaling in cancer – emerging role for SGK3
Bruhn MA, Pearson RB, Hannan RD, Sheppard KE
Cancer Management and Research 2013, 5:281-292
Published Date: 26 August 2013
3-Phosphoinositide-dependent protein kinase-1 as an emerging target in the management of breast cancer
Fyffe C, Falasca M
Cancer Management and Research 2013, 5:271-280
Published Date: 23 August 2013
Treatment challenges in the management of relapsed or refractory non-Hodgkin’s lymphoma – novel and emerging therapies
Chao MP
Cancer Management and Research 2013, 5:251-269
Published Date: 23 August 2013
Isolated limb infusion chemotherapy for melanoma: an overview of early experience at the Adelaide Melanoma Unit
Giles MH, Coventry BJ
Cancer Management and Research 2013, 5:243-249
Published Date: 20 August 2013
Samarium-153-ethylene diamine tetramethylene phosphonate, a beta-emitting bone-targeted radiopharmaceutical, useful for patients with osteoblastic bone metastases
Longo J, Lutz S, Johnstone C
Cancer Management and Research 2013, 5:235-242
Published Date: 13 August 2013
Targeting CD19 in B-cell lymphoma: emerging role of SAR3419
Raufi A, Ebrahim AS, Al-Katib A
Cancer Management and Research 2013, 5:225-233
Published Date: 27 August 2013
Cost-effectiveness of an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer in the UK
Humphreys S, Pellissier J, Jones A
Cancer Management and Research 2013, 5:215-224
Published Date: 8 August 2013
Anemia prevalence and treatment practice in patients with non-myeloid tumors receiving chemotherapy
Merlini L, Cartenì G, Iacobelli S, Stelitano C, Airoldi M, Balcke P, Keil F, Haslbauer F, Belton L, Pujol B
Cancer Management and Research 2013, 5:205-214
Published Date: 2 August 2013
Profile of vismodegib and its potential in the treatment of advanced basal cell carcinoma
Macha MA, Batra SK, Ganti AK
Cancer Management and Research 2013, 5:197-203
Published Date: 31 July 2013
The role of epithelial–mesenchymal transition programming in invasion and metastasis: a clinical perspective
Creighton CJ, Gibbons DL, Kurie JM
Cancer Management and Research 2013, 5:187-195
Published Date: 31 July 2013
Use and cardiovascular safety of transdermal and other granisetron preparations in cancer management
Mason JW, Moon TE
Cancer Management and Research 2013, 5:179-185
Published Date: 29 July 2013
Cancer-associated thrombosis: clinical presentation and survival
Amer MH
Cancer Management and Research 2013, 5:165-178
Published Date: 26 July 2013
The association of race with timeliness of care and survival among Veterans Affairs health care system patients with late-stage non-small cell lung cancer
Zullig LL, Carpenter WR, Provenzale DT, Weinberger M, Reeve BB, Williams CD, Jackson GL
Cancer Management and Research 2013, 5:157-163
Published Date: 24 July 2013
Orphan G protein receptor GPR55 as an emerging target in cancer therapy and management
Leyva-Illades D, DeMorrow S
Cancer Management and Research 2013, 5:147-155
Published Date: 1 July 2013
New and emerging combination therapies for esophageal cancer
Wiedmann MW, Mössner J
Cancer Management and Research 2013, 5:133-146
Published Date: 27 June 2013
When to perform positron emission tomography/computed tomography or radionuclide bone scan in patients with recently diagnosed prostate cancer
Caldarella C, Treglia G, Giordano A, Giovanella L
Cancer Management and Research 2013, 5:123-131
Published Date: 25 June 2013
Serous endometrial intraepithelial carcinoma: a case series and literature review
Pathiraja P, Dhar S, Haldar K
Cancer Management and Research 2013, 5:117-122
Published Date: 17 June 2013
Anti-VEGF agents in metastatic colorectal cancer (mCRC): are they all alike?
Saif MW
Cancer Management and Research 2013, 5:103-115
Published Date: 11 June 2013
Molecularly targeted approaches herald a new era of non-small-cell lung cancer treatment
Kaneda H, Yoshida T, Okamoto I
Cancer Management and Research 2013, 5:91-101
Published Date: 7 June 2013
Clinical outcome of incidentally discovered small renal cell carcinoma after delayed surgery
Sugimoto K, Shimizu N, Oki T, Nose K, Nishioka T, Adomi S, Ohzeki T, Esa A, Uemura H
Cancer Management and Research 2013, 5:85-89
Published Date: 24 May 2013
Prognostic factors of tumor recurrence in completely resected non-small cell lung cancer
Tantraworasin A, Seateang S, Lertprasertsuke N, Arreyakajohn N, Kasemsarn C, Patumanond J
Cancer Management and Research 2013, 5:77-84
Published Date: 6 June 2013
Nedaplatin: a cisplatin derivative in cancer chemotherapy
Shimada M, Itamochi H, Kigawa J
Cancer Management and Research 2013, 5:67-76
Published Date: 8 May 2013
Advanced medullary thyroid cancer: pathophysiology and management
Ferreira CV, Siqueira DR, Ceolin L, Maia AL
Cancer Management and Research 2013, 5:57-66
Published Date: 8 May 2013
Critical appraisal of the use of regorafenib in the management of colorectal cancer
Festino L, Fabozzi A, Manzo A, Gambardella V, Martinelli E, Troiani T, De Vita F, Orditura M, Ciardiello F, Morgillo F
Cancer Management and Research 2013, 5:49-55
Published Date: 12 April 2013
Economic evaluation of therapies for patients suffering from relapsed-refractory multiple myeloma in Greece
Fragoulakis V, Kastritis E, Psaltopoulou T, Maniadakis N
Cancer Management and Research 2013, 5:37-48
Published Date: 10 April 2013
Gastric cancer in young people under 30 years of age: worse prognosis, or delay in diagnosis?
Lopez-Basave HN, Morales-Vasquez F, Ruiz-Molina JM, Namendys-Silva SA, Vela-Sarmiento I, Ruan JM, Padilla Rosciano AE, Calderillo-Ruiz G, Diaz-Romero C, Herrera-Gomez A, Meneses-Garcia AA
Cancer Management and Research 2013, 5:31-36
Published Date: 4 April 2013
Long-term use of dasatinib in patients with metastatic castration-resistant prostate cancer after receiving the combination of dasatinib and docetaxel
Araujo JC, Trudel GC, Paliwal P
Cancer Management and Research 2013, 5:25-30
Published Date: 9 March 2013
Endoscopic endonasal approach for the treatment of a large clival giant cell tumor complicated by an intraoperative internal carotid artery rupture
Iacoangeli M, Di Rienzo A, Re M, Alvaro L, Nocchi N, Gladi M, De Nicola M, Scerrati M
Cancer Management and Research 2013, 5:21-24
Published Date: 30 January 2013
Evaluation of safety and efficacy of tivantinib in the treatment of inoperable or recurrent non-small-cell lung cancer
Broggini M, Garassino MC, Damia G
Cancer Management and Research 2013, 5:15-20
Published Date: 17 January 2013
Radium-223 chloride: a potential new treatment for castration-resistant prostate cancer patients with metastatic bone disease
Harrison MR, Wong TZ, Armstrong AJ, George DJ
Cancer Management and Research 2013, 5:1-14
Published Date: 8 January 2013